| Verona Pharma plc VRNA | $38.12M | 23.37 | 2.37M | 0% | +$0 | 4.99 | |
| Reneo Pharmaceuticals, Inc. RPHM | $3.73M | 6.73 | 2.25M | 0% | +$0 | 0.49 | |
ArriVent BioPharma, Inc. Common Stock AVBP | $34.72M | 5.8 | 1.94M | New | +$34.72M | 4.55 | |
Dianthus Therapeutics, Inc. DNTH | $41.42M | 4.7 | 1.38M | +149.22% | +$24.8M | 5.42 | |
| GlycoMimetics, Inc. GLYC | $9M | 4.65 | 3M | 0% | +$0 | 1.18 | |
| Gossamer Bio, Inc. GOSS | $10.84M | 4.06 | 9.19M | 0% | +$0 | 1.42 | |
Corbus Pharmaceuticals Holdings, Inc. CRBP | $15.89M | 3.79 | 405,000 | New | +$15.89M | 2.08 | |
AN2 Therapeutics, Inc. ANTX | $3.58M | 3.7 | 1.1M | +65.97% | +$1.42M | 0.47 | |
| AlloVir, Inc. ALVR | $3.17M | 3.65 | 4.2M | New | +$3.17M | 0.42 | |
| Tenaya Therapeutics, Inc. TNYA | $14.93M | 3.64 | 2.85M | New | +$14.93M | 1.95 | |
| Vincerx Pharma, Inc. VINC | $5.06M | 3.39 | 1M | New | +$5.06M | 0.66 | |
Jasper Therapeutics, Inc. JSPR | $14.7M | 3.32 | 500,811 | -88.79% | -$116.48M | 1.93 | |
Mind Medicine (MindMed) Inc. MNMD | $20.24M | 3 | 2.15M | New | +$20.24M | 2.65 | |
| Veru Inc. VERU | $2.66M | 2.6 | 3.8M | 0% | +$0 | 0.35 | |
Cybin Inc. CYBN | $7.69M | 2.5 | 18.6M | New | +$7.69M | 1.01 | |
| Apellis Pharmaceuticals, Inc. APLS | $164.99M | 2.31 | 2.81M | 0% | +$0 | 21.6 | |
Perspective Therapeutics, Inc. CATX | $17.51M | 2.31 | 14.72M | New | +$17.51M | 2.29 | |
| Annexon, Inc. ANNX | $14.7M | 2.22 | 2.05M | 0% | +$0 | 1.92 | |
| Ventyx Biosciences, Inc. VTYX | $8.26M | 2.13 | 1.5M | New | +$8.26M | 1.08 | |
| EyePoint Pharmaceuticals, Inc. EYPT | $22.6M | 2.1 | 1.09M | New | +$22.6M | 2.96 | |
| Centessa Pharmaceuticals plc CNTA | $23.28M | 1.82 | 2.06M | 0% | +$0 | 3.05 | |
| Taysha Gene Therapies, Inc. TSHA | $8.7M | 1.62 | 3.03M | New | +$8.7M | 1.14 | |
| Ocular Therapeutix, Inc. OCUL | $22.07M | 1.57 | 2.42M | New | +$22.07M | 2.89 | |
| Praxis Precision Medicines, Inc. PRAX | $15.87M | 1.52 | 260,000 | New | +$15.87M | 2.08 | |
| Aerovate Therapeutics, Inc. AVTE | $11.94M | 1.4 | 403,685 | 0% | +$0 | 1.56 | |
Dyne Therapeutics, Inc. DYN | $35.29M | 1.27 | 1.24M | +56.75% | +$12.78M | 4.62 | |
| PepGen Inc. PEPG | $5.53M | 1.16 | 376,117 | New | +$5.53M | 0.72 | |
Mineralys Therapeutics, Inc. MLYS | $7.1M | 1.11 | 550,000 | New | +$7.1M | 0.93 | |
Helix Acquisition Corp. II Class A Ordinary Shares HLXB | $2.59M | 1.09 | 250,000 | New | +$2.59M | 0.34 | |
| Structure Therapeutics Inc. GPCR | $21.71M | 1.09 | 506,604 | +22.37% | +$3.97M | 2.84 | |
| Viridian Therapeutics, Inc. VRDN | $10.86M | 0.97 | 620,000 | 0% | +$0 | 1.42 | |
| Terns Pharmaceuticals, Inc. TERN | $4.1M | 0.97 | 625,000 | New | +$4.1M | 0.54 | |
| RAPT Therapeutics, Inc. RAPT | $2.62M | 0.84 | 292,000 | 0% | +$0 | 0.34 | |
| Mersana Therapeutics, Inc. MRSN | $4.48M | 0.82 | 1M | New | +$4.48M | 0.59 | |
| Phathom Pharmaceuticals, Inc. PHAT | $4.83M | 0.78 | 455,000 | +810% | +$4.3M | 0.63 | |
| Insmed Incorporated INSM | $30.93M | 0.77 | 1.14M | -11.21% | -$3.91M | 4.05 | |
| Poseida Therapeutics, Inc. PSTX | $2.35M | 0.76 | 736,000 | New | +$2.35M | 0.31 | |
Silence Therapeutics plc SLN | $6.8M | 0.68 | 315,000 | New | +$6.8M | 0.89 | |
| Century Therapeutics, Inc. IPSC | $2.26M | 0.65 | 540,000 | New | +$2.26M | 0.3 | |
| AnaptysBio, Inc. ANAB | $3.72M | 0.6 | 165,000 | +37.5% | +$1.01M | 0.49 | |
| Nuvation Bio Inc. NUVB | $5M | 0.56 | 1.37M | +37.49% | +$1.36M | 0.66 | |
| Akero Therapeutics, Inc. AKRO | $8.59M | 0.49 | 340,000 | New | +$8.59M | 1.12 | |
| Fate Therapeutics, Inc. FATE | $3.82M | 0.46 | 520,800 | New | +$3.82M | 0.5 | |
| BridgeBio Pharma, Inc. BBIO | $21.33M | 0.37 | 690,000 | -2.38% | -$519,456.00 | 2.79 | |
| Allogene Therapeutics, Inc. ALLO | $3.22M | 0.35 | 720,000 | New | +$3.22M | 0.42 | |
| Nkarta, Inc. NKTX | $2.59M | 0.34 | 240,000 | New | +$2.59M | 0.34 | |
| Arrowhead Pharmaceuticals, Inc. ARWR | $7.15M | 0.2 | 250,000 | New | +$7.15M | 0.94 | |
| Immunovant, Inc. IMVT | $8.83M | 0.19 | 273,289 | 0% | +$0 | 1.16 | |
| Cytokinetics, Incorporated CYTK | $13.6M | 0.17 | 194,000 | +67.24% | +$5.47M | 1.78 | |
| Sana Biotechnology, Inc. SANA | $3.61M | 0.16 | 360,800 | New | +$3.61M | 0.47 |